学术论文: |
1. G. Ding, S. Liu, X. Yang, H. Lv, M. Jia1, J. Li* R Zhang*. Metabolizable alloy clusters assemble nanoinhibitor for enhanced radiotherapy of tumor by hypoxia alleviation and intracellular PD-L1 restraint. Journal of Nanobiotechnology. 2024, 22 :774. (IF= 10.6) 2. R. Zhang*, M. Jia, H. Lv, M. Li, G. Ding, G. Cheng, J. Li*. Assembling Au8 clusters on surfaces of bifunctional nanoimmunomodulators for synergistically enhanced low dose radiotherapy of metastatic tumor.Journal of Nanobiotechnology. 2024, 22 :20, (IF= 10.6) 3. R. Zhang, Z. Zhu, H. Lv, F. Li, S. Sun, J. Li*, C.-S. Lee*. Immune Checkpoint Blockade Mediated by Small-molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer. Small. 2019, 1903881 (IF=13.3). 4. R. Zhang, Y. Guan, Z. Zhu, H. Lv, F. Li, S. Sun, J. Li*. Multifunctional Tetracene/Pentacene Host/Guest Nanorods for Enhanced Upconversion Photodynamic Tumor Therapy. ACS Appl. Mater. Interfaces 2019, 11, 37479−37490. (IF = 9.5) 5. R. Zhang, G. Cheng, S. Liu, H. Lv, J. Li*. A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer. J. Mater. Chem. B, 2021, 9, 8809. (IF=7.0). 6. R. Zhang, Y. Wan, H. Lv, F. Li, C. -S. Lee*. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemoimmunotherapy. J. Mater. Chem. B, 2021, 9, 7544. (IF=7.0). 7. M. Li, G. Cheng, R. Zhang*, J. Li*. Simple Multifunctional PTX@Ce6 Nanomedicine for Eradicating Tumor in the Combination of Photodynamic Therapy and Metronomic Chemotherapy. ACS Omega 2022, 7, 48372. 8 R. Zhang*, G Cheng, M. Li, H. Lv, J. Li*. Pentacene Nanorods as Effective Photosensitizers for Photodynamic Therapy of Tumors via Singlet Fission. Part. Part. Syst. Charact. 2023, 40, 2200174. 9. R. Zhang =6.4 10. ,960(IF=6.7). 11. . 12. . 13. . 14. . 15. .(IF=6.2)
|